VRTX - Vertex Pharmaceuticals Incorporated
| Previous close | 272.82 |
| Open | 270.82 |
| Bid | 269.37 x 800 |
| Ask | 269.75 x 1300 |
| Day's range | 266.90 - 271.68 |
| 52-week range | 165.23 - 295.55 |
| Volume | 376,480 |
| Avg. volume | 2,285,918 |
| Market cap | 69.686B |
| Beta (5Y monthly) | 1.47 |
| PE ratio (TTM) | 32.61 |
| EPS (TTM) | 8.24 |
| Earnings date | 29 Jul 2020 - 03 Aug 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 283.91 |
- Zacks
Looking for Earnings Beat? Play These 5 Stocks
Invest in top-ranked stocks that are likely to beat their earnings estimates in the upcoming releases.
- Zacks
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Markets: What You Should Know
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $272.82, moving -1.51% from the previous trading session.
- Zacks
Zacks Market Edge Highlights: Vertex Pharmaceuticals, Channel Advisor, Gold Fields, AngloGold Ashanti and Dropbox
Zacks Market Edge Highlights: Vertex Pharmaceuticals, Channel Advisor, Gold Fields, AngloGold Ashanti and Dropbox
- Zacks
5 Strong Buy Growth Stocks for this Secular Bull Rally
How can the stock market be near another all-time high with a pandemic and 40 million unemployed? Secular bull markets don't care about headlines.
- Business Wire
Vertex Appoints Diana McKenzie to its Board of Directors
Vertex today announced that Diana McKenzie has been appointed to its board of directors as an independent director.
- Zacks
Zacks.com featured highlights include: Vertex Pharmaceuticals, Dollar General, CVS Health and Tractor Supply
Zacks.com featured highlights include: Vertex Pharmaceuticals, Dollar General, CVS Health and Tractor Supply
- Zacks
4 Stocks That Flaunt an Impressive Interest Coverage Ratio
Interest coverage ratio is used to determine how effectively a company can pay the interest charged on its debt.
- Zacks
3 Strong Pharmaceutical and Biotech Stocks to Buy for Coronavirus Immunity
Let's dive into three large-cap pharmaceutical and biotech stocks that appear set to grow during the pandemic-induced downturn and the eventual recovery...
- Motley Fool
2 Best Biotech Stocks to Buy Right Now
Revenue is climbing at these biotech companies. And one of them is waiting for what could be an historic product approval.
- Zacks
Why Is Vertex (VRTX) Up 10.4% Since Last Earnings Report?
Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Motley Fool
Got $3,000? Here Are 3 Great Biotech Stocks to Buy Right Now
While the broader market indexes are still down year to date despite strong rebounds in recent weeks, the major biotech exchange-traded funds (ETFs) are in solid positive territory for the year. Granted, not all biotech stocks are doing well. If you've got $3,000 to invest, here are three great biotech stocks to buy right now that have what it takes for long-term success.
- Zacks
Zacks.com featured highlights include: BJs Wholesale Club, Fortinet, Vertex Pharmaceuticals, SPS Commerce and Repligen
Zacks.com featured highlights include: BJs Wholesale Club, Fortinet, Vertex Pharmaceuticals, SPS Commerce and Repligen
- Zacks
VRTX vs. ILMN: Which Stock Should Value Investors Buy Now?
VRTX vs. ILMN: Which Stock Is the Better Value Option?
- Zacks
Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?
Is (VRTX) Outperforming Other Medical Stocks This Year?
- Zacks
Profit From 5 Stocks Likely to Beat on Earnings
Bet on five stocks that are likely to outdo earnings estimates.
- Zacks
2 Top Factors Buoy Wall Street Since Memorial Day: 5 Picks
As optimism surrounding a coronavirus vaccine and consumer activity begin to pick up, Wall Street is expected to trade higher.
- Motley Fool
Is Vertex Pharmaceuticals Stock a Buy?
The answer is yes. There's no need to build any suspense. Vertex Pharmaceuticals (NASDAQ: VRTX) is definitely a great stock to buy right now, in my view. I've owned the biotech stock for a couple of years.
- Stockopedia
The Vertex Pharmaceuticals Inc share price at 283.75: three reasons it could go higher
Often the real stock market winners are not shares that look obviously cheap compared to book value or earnings – instead they are the slightly more expensive,...
- Zacks
The Zacks Analyst Blog Highlights: Chegg, Quidel, MarketAxess, Dropbox and Vertex Pharmaceuticals
The Zacks Analyst Blog Highlights: Chegg, Quidel, MarketAxess, Dropbox and Vertex Pharmaceuticals
- Zacks
The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals
The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals
- Motley Fool
2 Top Biotech Picks for May
The art of biotech investing requires a great deal of scientific knowledge, awareness of financials, and patience in waiting for clinical trials to come to fruition. Today, let's examine two of the best biotech stocks in the industry; both are companies making rapid progress in treating patients with significant medical needs. Compugen (NASDAQ: CGEN) specializes in clinical-stage cancer immunotherapies, which have proprietary algorithms used to detect specific sequences within protein receptors that regulate the immune system and inhibit autoimmune activity.
- Zacks
The Zacks Analyst Blog Highlights: The Hain Celestial Group, Murphy USA, Vertex Pharmaceuticals, Sprouts Farmers Market and ASE Technology
The Zacks Analyst Blog Highlights: The Hain Celestial Group, Murphy USA, Vertex Pharmaceuticals, Sprouts Farmers Market and ASE Technology
- Zacks
Vertex Pharmaceuticals, Align Technology, Walmart, Home Depot and Target highlighted as Zacks Bull and Bear of the Day
Vertex Pharmaceuticals, Align Technology, Walmart, Home Depot and Target highlighted as Zacks Bull and Bear of the Day
- Motley Fool
3 Great Stocks to Buy If You Get a Second Stimulus Check
Uncle Sam could be sending more money your way in the not-too-distant future. Buying these stocks will put the extra cash to good use.
- Zacks
Major Indexes Defying "Sell in May" Adage: 5 Growth Picks
Half of this month is already over, yet Wall Street is in green defying the well-known financial-world adage "Sell in May and go away."
